Differentiation and long-term survival of C2C12 myoblast grafts in heart

Gou Young Koh, Michael G. Klug, Mark Soonpaa, Loren Field

Research output: Contribution to journalArticle

224 Citations (Scopus)

Abstract

We have assessed the ability of skeletal myoblasts to form long-term, differentiated grafts in ventricular myocardium. C2C12 myoblasts were grafted directly into the heart of syngeneic mice. Viable grafts were observed as long as 3 mo after implantation. Immunohistological analyses revealed the presence of differentiated myotubes that stably expressed the skeletal myosin heavy chain isoform. Thymidine uptake studies indicated that virtually all of the grafted skeletal myocytes were withdrawn from the cell cycle by 14 d after grafting. Graft myocytes exhibited ultrastructural characteristics typical of differentiated myotubes. Graft formation and the associated myocardial remodeling did not induce overt cardiac arrhythmia. This study indicates that the myocardium can serve as a stable platform for skeletal myoblast grafts. The long-term survival, differentiated phenotype, and absence of sustained proliferative activity observed in myoblast grafts raise the possibility that similar grafting approaches may be used to replace diseased myocardium. Furthermore, the genetic tractability of myoblasts could provide a useful means for the local delivery of recombinant molecules to the heart.

Original languageEnglish
Pages (from-to)1548-1554
Number of pages7
JournalJournal of Clinical Investigation
Volume92
Issue number3
StatePublished - Sep 1993

Fingerprint

Myoblasts
Transplants
Skeletal Muscle Fibers
Skeletal Myoblasts
Myocardium
Myosin Heavy Chains
Thymidine
Muscle Cells
Cardiac Arrhythmias
Cell Cycle
Protein Isoforms
Phenotype

Keywords

  • Cell transplantation
  • Gene therapy
  • Intracardiac grafts
  • Myocardial repair
  • Skeletal myoblasts

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Differentiation and long-term survival of C2C12 myoblast grafts in heart. / Koh, Gou Young; Klug, Michael G.; Soonpaa, Mark; Field, Loren.

In: Journal of Clinical Investigation, Vol. 92, No. 3, 09.1993, p. 1548-1554.

Research output: Contribution to journalArticle

@article{4f2e41a3b5ce4a379082f940b60ad278,
title = "Differentiation and long-term survival of C2C12 myoblast grafts in heart",
abstract = "We have assessed the ability of skeletal myoblasts to form long-term, differentiated grafts in ventricular myocardium. C2C12 myoblasts were grafted directly into the heart of syngeneic mice. Viable grafts were observed as long as 3 mo after implantation. Immunohistological analyses revealed the presence of differentiated myotubes that stably expressed the skeletal myosin heavy chain isoform. Thymidine uptake studies indicated that virtually all of the grafted skeletal myocytes were withdrawn from the cell cycle by 14 d after grafting. Graft myocytes exhibited ultrastructural characteristics typical of differentiated myotubes. Graft formation and the associated myocardial remodeling did not induce overt cardiac arrhythmia. This study indicates that the myocardium can serve as a stable platform for skeletal myoblast grafts. The long-term survival, differentiated phenotype, and absence of sustained proliferative activity observed in myoblast grafts raise the possibility that similar grafting approaches may be used to replace diseased myocardium. Furthermore, the genetic tractability of myoblasts could provide a useful means for the local delivery of recombinant molecules to the heart.",
keywords = "Cell transplantation, Gene therapy, Intracardiac grafts, Myocardial repair, Skeletal myoblasts",
author = "Koh, {Gou Young} and Klug, {Michael G.} and Mark Soonpaa and Loren Field",
year = "1993",
month = "9",
language = "English",
volume = "92",
pages = "1548--1554",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - Differentiation and long-term survival of C2C12 myoblast grafts in heart

AU - Koh, Gou Young

AU - Klug, Michael G.

AU - Soonpaa, Mark

AU - Field, Loren

PY - 1993/9

Y1 - 1993/9

N2 - We have assessed the ability of skeletal myoblasts to form long-term, differentiated grafts in ventricular myocardium. C2C12 myoblasts were grafted directly into the heart of syngeneic mice. Viable grafts were observed as long as 3 mo after implantation. Immunohistological analyses revealed the presence of differentiated myotubes that stably expressed the skeletal myosin heavy chain isoform. Thymidine uptake studies indicated that virtually all of the grafted skeletal myocytes were withdrawn from the cell cycle by 14 d after grafting. Graft myocytes exhibited ultrastructural characteristics typical of differentiated myotubes. Graft formation and the associated myocardial remodeling did not induce overt cardiac arrhythmia. This study indicates that the myocardium can serve as a stable platform for skeletal myoblast grafts. The long-term survival, differentiated phenotype, and absence of sustained proliferative activity observed in myoblast grafts raise the possibility that similar grafting approaches may be used to replace diseased myocardium. Furthermore, the genetic tractability of myoblasts could provide a useful means for the local delivery of recombinant molecules to the heart.

AB - We have assessed the ability of skeletal myoblasts to form long-term, differentiated grafts in ventricular myocardium. C2C12 myoblasts were grafted directly into the heart of syngeneic mice. Viable grafts were observed as long as 3 mo after implantation. Immunohistological analyses revealed the presence of differentiated myotubes that stably expressed the skeletal myosin heavy chain isoform. Thymidine uptake studies indicated that virtually all of the grafted skeletal myocytes were withdrawn from the cell cycle by 14 d after grafting. Graft myocytes exhibited ultrastructural characteristics typical of differentiated myotubes. Graft formation and the associated myocardial remodeling did not induce overt cardiac arrhythmia. This study indicates that the myocardium can serve as a stable platform for skeletal myoblast grafts. The long-term survival, differentiated phenotype, and absence of sustained proliferative activity observed in myoblast grafts raise the possibility that similar grafting approaches may be used to replace diseased myocardium. Furthermore, the genetic tractability of myoblasts could provide a useful means for the local delivery of recombinant molecules to the heart.

KW - Cell transplantation

KW - Gene therapy

KW - Intracardiac grafts

KW - Myocardial repair

KW - Skeletal myoblasts

UR - http://www.scopus.com/inward/record.url?scp=0027279257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027279257&partnerID=8YFLogxK

M3 - Article

VL - 92

SP - 1548

EP - 1554

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -